Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
17.77
-0.60 (-3.27%)
At close: Feb 21, 2025, 4:00 PM
17.53
-0.24 (-1.35%)
After-hours: Feb 21, 2025, 6:38 PM EST
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$612,558
Profits / Employee
-$462,558
Market Cap
1.22B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
ARVN News
- 9 days ago - These Analysts Revise Their Forecasts On Arvinas After Q4 Results - Benzinga
- 10 days ago - Arvinas, Inc. (ARVN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Arvinas Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 19 days ago - Arvinas to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025 - GlobeNewsWire
- 6 weeks ago - Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 2 months ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire